SRDX
ANALYST COVERAGE7 analysts
BUY
-8.1%downside to target
L $36.00
Med $39.50consensus
H $43.00
Strong Buy
114%
Buy
343%
Hold
229%
Sell
114%
4 Buy (57%)2 Hold (29%)1 Sell (14%)
Full report →
Key MetricsTTM
Market Cap$614.51M
Revenue TTM$120.80M
Net Income TTM-$17.63M
Free Cash Flow
Gross Margin72.8%
Operating Margin-13.4%
Net Margin-16.2%
Return on Equity-12.8%
Return on Assets-8.3%
Debt / Equity0.29
Current Ratio3.91
EPS TTM$-0.99
PRICE
Prev Close
42.98
Open
42.98
Day Range
52W Range25.87 – 43.00
25.87
43.00
100% of range
VOLUME & SIZE
Avg Volume
436.0K
FUNDAMENTALS
P/E Ratio
-34.7x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
1.11
Market-like
TECHNICAL
RSI (14)
86
Overbought
Upcoming Events
EEarnings Report
Tomorrow
May 24
DEx-Dividend
In 90 days
Aug 21
PDividend Pay
In 108 days
Sep 8

SRDX News

About

surmodics partners with the world's leading and emerging medical device, diagnostic and life sciences companies to develop and commercialize innovative products designed to improve lives by enabling the detection and treatment of disease. following two recent acquisitions, the company is transforming its medical device business from being a provider of coating technologies, to offering whole-product solutions. throughout its transformation, surmodics’ mission remains: to improve the detection and treatment of disease by using our technology to provide solutions to difficult medical device and diagnostic challenges.

Industry
Surgical and Medical Instrument Manufacturing
CEO
Gary Maharaj
Joel SuiterDirector of Corporate Development
Charles W. OlsonSenior Vice President & President of Medical Device Coatings
Gary R. MaharajChief Executive Officer, President & Director
Gordon S. WeberSenior Vice President of Legal, General Counsel & Secretary
John D. MandersCorporate Controller, Vice President of Finance & Principal Accounting Officer
Joseph J. StichSenior Vice President of Human Resources & President of In Vitro Diagnostics
Timothy J. ArensSenior Vice President of Finance & Information Technology and Chief Financial Officer
Teryl L. W. SidesSenior Vice President & President of Vascular Interventions